Submitted by kBLASTER Team on
by Medtronic
MINNEAPOLIS - December 15, 2014 - Medtronic (NYSE: MDT) today announced the launch of the NovaShield(TM) Injectable Nasal Packing and Stent for functional endoscopic sinus surgery (FESS), manufactured by the company's Ear Nose and Throat (ENT) division of its Surgical Technologies business. Made from chitosan, NovaShield is a ready-to-use gel placed in the sinus or nasal cavities following FESS. It helps to control minimal bleeding, prevent adhesions, and has provided a level of antibacterial effectiveness in in vitro testing.* NovaShield is biofragmentable and eliminates the need for painful packing removal associated with traditional sponge or gauze nasal packing. NovaShield received FDA 510(k) clearance from the U.S. Food and Drug Administration on October 6, 2014.
Go to kBLASTER for FDA 510(k) predicate search with effective result management to build your successful 510(k) clearance strategy.